Announced Fri, 13 Mar · 09:47 IST
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sudhir Sethi
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.4%1-day move
₹20.99
prior close
—
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-1.4-8.3-4.7+0.0+2.0+0.0+19.1+13.6-2.3+12.0
Up moveDown movePending
AI summary
Sudhir Sethi, the main promoter of Beryl Drugs Limited, acquired 4,853 equity shares (0.10%) of the company through open market transactions on 11-03-2026. His holding increased from 4,50,290 shares (8.88%) to 4,55,143 shares (8.98%) of the total share capital of 50,71,700 shares. The disclosure was filed under Regulation 29(2) of SEBI (SAST) Regulations, 2011.
Likely market impact
The promoter marginally increased his stake, signaling continued confidence in the company. However, the acquisition is very small (0.10%), so it is unlikely to materially impact the stock price.